Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Pediatrix Medical Group Inc (NYSE: MD) closed at $21.54 in the last session, down -3.02% from day before closing price of $22.21. In other words, the price has decreased by -$3.02 from its previous closing price. On the day, 0.62 million shares were traded. MD stock price reached its highest trading level at $22.115 during the session, while it also had its lowest trading level at $21.4.
Ratios:
We take a closer look at MD’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.77. For the most recent quarter (mrq), Quick Ratio is recorded 1.83 and its Current Ratio is at 1.83. In the meantime, Its Debt-to-Equity ratio is 0.72 whereas as Long-Term Debt/Eq ratio is at 0.68.
On September 26, 2024, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $8 to $14.
Deutsche Bank Upgraded its Sell to Hold on June 07, 2024, while the target price for the stock was maintained at $8.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 15 ’25 when ORDAN MARK S sold 23,000 shares for $22.41 per share. The transaction valued at 515,430 led to the insider holds 302,805 shares of the business.
ORDAN MARK S bought 23,000 shares of MD for $517,500 on Dec 15 ’25. On Nov 17 ’25, another insider, Rucker Michael A., who serves as the Director of the company, sold 10,478 shares for $23.00 each. As a result, the insider received 240,994 and left with 59,101 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MD now has a Market Capitalization of 1875793536 and an Enterprise Value of 1992427392. As of this moment, Pediatrix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.37, and their Forward P/E ratio for the next fiscal year is 9.85. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.65. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.96 while its Price-to-Book (P/B) ratio in mrq is 2.08. Its current Enterprise Value per Revenue stands at 1.036 whereas that against EBITDA is 7.735.
Stock Price History:
The Beta on a monthly basis for MD is 0.76, which has changed by 0.46730244 over the last 52 weeks, in comparison to a change of 0.15024745 over the same period for the S&P500. Over the past 52 weeks, MD has reached a high of $24.99, while it has fallen to a 52-week low of $11.84. The 50-Day Moving Average of the stock is -3.97%, while the 200-Day Moving Average is calculated to be 27.39%.
Shares Statistics:
According to the various share statistics, MD traded on average about 935.56K shares per day over the past 3-months and 536880 shares per day over the past 10 days. A total of 85.83M shares are outstanding, with a floating share count of 84.53M. Insiders hold about 1.57% of the company’s shares, while institutions hold 96.01% stake in the company. Shares short for MD as of 1767139200 were 3035860 with a Short Ratio of 3.24, compared to 1764288000 on 3161380. Therefore, it implies a Short% of Shares Outstanding of 3035860 and a Short% of Float of 4.97.
Earnings Estimates
. The current assessment of Pediatrix Medical Group Inc (MD) involves the perspectives of 7.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.38, with high estimates of $0.41 and low estimates of $0.36.
Analysts are recommending an EPS of between $2.16 and $2.05 for the fiscal current year, implying an average EPS of $2.08. EPS for the following year is $2.19, with 7.0 analysts recommending between $2.39 and $2.11.
Revenue Estimates
According to 7 analysts,. The current quarter’s revenue is expected to be $486.23M. It ranges from a high estimate of $521.66M to a low estimate of $465.47M. The current estimate, Pediatrix Medical Group Inc’s year-ago sales were $502.36MFor the next quarter, 7 analysts are estimating revenue of $473.79M. There is a high estimate of $479.8M for the next quarter, whereas the lowest estimate is $467.53M.
A total of 7 analysts have provided revenue estimates for MD’s current fiscal year. The highest revenue estimate was $1.94B, while the lowest revenue estimate was $1.89B, resulting in an average revenue estimate of $1.91B. In the same quarter a year ago, actual revenue was $2.01BBased on 7 analysts’ estimates, the company’s revenue will be $1.96B in the next fiscal year. The high estimate is $2.02B and the low estimate is $1.88B.
